Screen Flags 3 Penny Stocks for Higher Rates as 3,616 More Pass Financial-Fit Filters
Updated
Updated · Simply Wall St · Aug 15
Screen Flags 3 Penny Stocks for Higher Rates as 3,616 More Pass Financial-Fit Filters
1 articles · Updated · Simply Wall St · Aug 15
Summary
A Simply Wall St screen highlighted Ardelyx, Alkane Resources and Clover Health as penny stocks with stronger balance sheets that may better withstand a higher-for-longer rate backdrop.
Tighter global rate expectations are keeping borrowing costs elevated, a pressure point that can hit smaller, more indebted companies hardest and makes financial resilience a key filter.
Ardelyx posted about $450.9 million in revenue and recent record Q2 2026 sales, but investors still weigh its narrow drug portfolio and Medicare reimbursement disputes over XPHOZAH.
Alkane, with a roughly A$2.1 billion market cap, pairs record production and a 22.5% net margin with mining complexity and funding demands tied to the long-dated Boda-Kaiser project.
Clover Health generated roughly $2.48 billion in revenue and raised 2026 guidance, though its newly emerging profitability still depends heavily on Medicare policy and access to outside funding.